These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 6453157)

  • 21. Alterations in cyclic nucleotides and cyclase-specific activities in T lymphocytes of aging normal humans and patients with Down's syndrome.
    Tam CF; Walford RL
    J Immunol; 1980 Oct; 125(4):1665-70. PubMed ID: 6106029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proapoptotic activated T-cells in the blood of children with Down's syndrome: relationship with dietary antigens and intestinal alterations.
    Corsi MM; Ponti W; Venditti A; Ferrara F; Baldo C; Chiappelli M; Licastro F
    Int J Tissue React; 2003; 25(3):117-25. PubMed ID: 14756193
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Down syndrome B-lymphocyte subpopulations, intrinsic defect or decreased T-lymphocyte help.
    Verstegen RH; Kusters MA; Gemen EF; DE Vries E
    Pediatr Res; 2010 May; 67(5):563-9. PubMed ID: 20098344
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunoglobulin levels, T-cell markers, mitogen responsiveness and thymic hormone activity in Turner's syndrome.
    Lorini R; Ugazio AG; Cammareri V; Larizza D; Castellazzi AM; Brugo MA; Severi F
    Thymus; 1983 Mar; 5(2):61-6. PubMed ID: 6602404
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Diminished zinc plasma concentrations and alterations in the number of lymphocyte subpopulations in Down's syndrome patients].
    Soto-Quintana M; Alvarez-Nava F; Rojas-Atencio A; Granadillo V; Fernández D; Ocando A; López E; Fulcado W
    Invest Clin; 2003 Mar; 44(1):51-60. PubMed ID: 12703183
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thymic hormone deficiency in normal ageing and Down's syndrome: is there a primary failure of the thymus?
    Fabris N; Mocchegiani E; Amadio L; Zannotti M; Licastro F; Franceschi C
    Lancet; 1984 May; 1(8384):983-6. PubMed ID: 6143966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autologous rosette-forming T cells as the responding cells in human autologous mixed-lymphocyte reaction.
    Palacios R; Llorente L; Alarcón-Segovia D; Ruíz-Arguelles A; Díaz-Jouanen E
    J Clin Invest; 1980 Jun; 65(6):1527-30. PubMed ID: 6447710
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thymic deficiency in Down's syndrome.
    Levin S; Schlesinger M; Handzel Z; Hahn T; Altman Y; Czernobilsky B; Boss J
    Pediatrics; 1979 Jan; 63(1):80-7. PubMed ID: 155804
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Down's syndrome: problems of immunodeficiency.
    Ugazio AG
    Hum Genet Suppl; 1981; 2():33-9. PubMed ID: 6218139
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impaired autologous and allogeneic mixed lymphocyte reaction in human marrow transplant recipients.
    Mori T; Tsoi MS; Dobbs S; Thomas ED; Storb R
    Exp Hematol; 1983 May; 11(5):425-34. PubMed ID: 6221939
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Leucocyte migration inhibition factor (LIF) production by lymphocytes of normal children, newborns, and children with immune deficiency.
    Hahn T; Levin S; Handzel ZT
    Clin Exp Immunol; 1976 Jun; 24(3):448-54. PubMed ID: 133010
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral zinc supplementation in Down's syndrome: restoration of thymic endocrine activity and of some immune defects.
    Franceschi C; Chiricolo M; Licastro F; Zannotti M; Masi M; Mocchegiani E; Fabris N
    J Ment Defic Res; 1988 Jun; 32 ( Pt 3)():169-81. PubMed ID: 2971113
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autologous mixed lymphocyte reaction in man. X. T-T autologous mixed lymphocyte reaction in young and aging humans.
    Gupta S
    J Clin Lab Immunol; 1984 Jun; 14(2):107-9. PubMed ID: 6235371
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Blood zinc in patients with Down's syndrome and its relations with their immune status].
    Colombo ML; Givrardo E; Ricci BM; Maina D
    Minerva Pediatr; 1989 Feb; 41(2):71-5. PubMed ID: 2525662
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thymic involution in pregnant mice. II. Functional aspects of the remaining thymocytes.
    Phuc LH; Papiernik M; Dardenne M
    Clin Exp Immunol; 1981 May; 44(2):253-61. PubMed ID: 6458427
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of thymus factor and levamisole treatment in patients with persistent nephrotic syndrome.
    Czekalski S; Sulima D; Strzelecka G
    Proc Eur Dial Transplant Assoc; 1983; 19():800-3. PubMed ID: 6603617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.
    Sikora E; Radziszewska E; Kmieć T; Maślińska D
    Acta Biochim Pol; 1993; 40(2):269-72. PubMed ID: 8212965
    [TBL] [Abstract][Full Text] [Related]  

  • 38. T system immune-deficiency in Down's syndrome.
    Levin S; Nir E; Mogilner BM
    Pediatrics; 1975 Jul; 56(1):123-6. PubMed ID: 125869
    [No Abstract]   [Full Text] [Related]  

  • 39. Interferon-gamma- and interleukin-4-producing T cells in Down's syndrome.
    Franciotta D; Verri A; Zardini E; Andreoni L; De Amici M; Moratti R; Nespoli L
    Neurosci Lett; 2006 Feb; 395(1):67-70. PubMed ID: 16289322
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impaired antigen presentation in toxic epidermal necrolysis.
    Bagot M; Charue D; Heslan M; Wechsler J; Roujeau JC; Revuz J
    Arch Dermatol; 1993 Jun; 129(6):721-7. PubMed ID: 8507074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.